…challenges of Lyme disease diagnosis and the sensitivities and specificities of both clinical features and laboratory tests. In conjunction with its companion paper on the epidemiology of Lyme disease (Purple…
…press release – March 25, 2021 16 Efficacy studies – two doses; symptomatic disease https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 https://www.nejm.org/doi/full/10.1056/NEJMoa2035389 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00432-3/fulltext https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html Efficacy studies – one dose; symptomatic disease 17 Estimate Description Reference 92%…
…and Complex Systems (BIOCOM-SC). Department of Physics. Universitat Politècnica de Catalunya, Castelldefels, Spain 17 Fundació Sant Joan de Déu, Barcelona, Spain. 18 Department of Medicine, Universitat Internacional de Catalunya, Barcelona,…
…à trois lorsque tous les sujets d’une population sont susceptibles. C’est un taux relativement faible si on le compare à d’autres maladies comme la rougeole ou la tuberculose. Les mesures…
…19. Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, et al. ANRS-COM’TEST: description of a community-based HIV testing intervention in non-medical settings for men who…
…to or targeted for communities and individuals that experience disadvantage. 45. The public health agency communication strategy includes plans and/or procedures for ensuring cultural competency and/or sensitivity to impacted communities…
…demonstrated understanding and skill in cultural competency and ability to communicate in languages of the community including sign language. 43. The public health agency has access to communications personnel that…
…pH1N1 vaccine containing 1.9 µg of HA to provide adequate protection in children less than 9 years of age. The inherent trade-off between community-level risk versus individual-level risk warrants recognition….
…Resource for Public HealthDownload Slides: Monali Varia – Wastewater Surveillance for SARS-CoV-2 in Peel region, OntarioDownload Slides: Michael-Becker – Wastewater Surveillance for Northern, Remote, or Isolated (NRI) CommunitiesDownload Synopsis In…
…Available at: http://www.phac-aspc.gc.ca/alert- alerte/h1n1/faq/faq_rg_h1n1-fvv-eng.php#fq3. Accessed Oct 30, 2010. 9. GlaxoSmithKline. GlaxoSmithKline Inc. Appearance before the standing committee on health. 2009; Available at: http://www.gsk.ca/ english/docs-pdf/PNL_Hearing_Remarks_ Oct_26th_ENG.pdf. Accessed August 1, 2010. 10….
…Available at: http://www.phac-aspc.gc.ca/alert- alerte/h1n1/faq/faq_rg_h1n1-fvv-eng.php#fq3. Accessed Oct 30, 2010. 9. GlaxoSmithKline. GlaxoSmithKline Inc. Appearance before the standing committee on health. 2009; Available at: http://www.gsk.ca/ english/docs-pdf/PNL_Hearing_Remarks_ Oct_26th_ENG.pdf. Accessed August 1, 2010. 10….
…www.ccnmi.ca. NCCID Project No. 147 ISBN 978-1-927988-10-7 515 PORTAGE AVENUE, WINNIPEG, MB R3B 2E9 204.943.0051 NCCID@ICID.COM WWW.NCCID.CA Understanding the Measurement of Global Burden of Disease Julie Lajoie, PhD Prepared for…